Back to search
Oligodendroglioma; Oligoastrocytoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oligodendroglioma; Oligoastrocytoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Oligodendroglioma; Oligoastrocytoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an open-label, multi-center, Phase 1/2 study of the brain-penetrant MEK inhibitor, mirdametinib (PD-0325901), in patients with pediatric low-grade gliom…
This phase II trial studies how well temozolomide and radiation therapy work in treating patients with IDH wildtype historically lower grade gliomas or non-hist…
This randomized phase II clinical trial studies the side effects and how well proton beam or intensity-modulated radiation therapy works in preserving brain fun…
This phase I trial studies the side effects and best dose of carboxylesterase-expressing allogeneic neural stem cells when given together with irinotecan hydroc…